Name and surname:
|
Mgr. Agáta Očenášová
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Laboratory Diagnostician | Medirex a.s., Bratislava | 2020-2022 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Immunology | General Medicine | 2nd Degree | General Medicine |
Ocenasova A, Shawkatova I, Javor J, et al. MMP2 rs243866 and rs2285053 Polymorphisms and Alzheimer's Disease Risk in Slovak Caucasian Population. Life (Basel). 2023;13(4):882. (IF = 3,2; Q2)
Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Reznakova V, Kralova M, Hromadka T, Shawkatova I. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642. (IF = 4,53; Q2)
Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Kiralyova I, Sutovsky S, Petrovic R, Shawkatova I. TREM2 coding variants in Slovak Alzheimer's disease patients. Journal of integrative neuroscience. 2022;21(4):105. (IF = 1,8; Q3)
Durmanova V, Tedla M, Rada D, Bandzuchova H, Kuba D, Suchankova M, Ocenasova A, Bucova M. Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients. Diseases (Basel, Switzerland). 2024;12(2):34. (IF = 3,7; Q2)
Ocenasova A, Shawkatova I, Javor J, et al. MMP2 rs243866 and rs2285053 Polymorphisms and Alzheimer's Disease Risk in Slovak Caucasian Population. Life (Basel). 2023;13(4):882. (IF = 3,2; Q2)
Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Reznakova V, Kralova M, Hromadka T, Shawkatova I. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642. (IF = 4,53; Q2)
Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Kiralyova I, Sutovsky S, Petrovic R, Shawkatova I. TREM2 coding variants in Slovak Alzheimer's disease patients. Journal of integrative neuroscience. 2022;21(4):105. (IF = 1,8; Q3)
Durmanova V, Tedla M, Rada D, Bandzuchova H, Kuba D, Suchankova M, Ocenasova A, Bucova M. Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients. Diseases (Basel, Switzerland). 2024;12(2):34.(IF = 3,7; Q2)
article: Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, et al. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642.
cited by: Pintér P, Alpár A. The Role of Extracellular Matrix in Human Neurodegenerative Diseases. International journal of molecular sciences 2022;23(19):11085. (Q1)
article: Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, et al. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642.
cited by: Xu Y, Yan H, Zhang X, et al. Roles of Altered Macrophages and Cytokines: Implications for Pathological Mechanisms of Postmenopausal Osteoporosis, Rheumatoid Arthritis, and Alzheimer's Disease. Frontiers in endocrinology. 2022;13:876269. (Q1)
article: Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, et al. TREM2 coding variants in Slovak Alzheimer's disease patients. Journal of integrative neuroscience. 2022;21(4):105.
cited by: Shang X, Maimaiti N, Fan J, et al. Triggering Receptor Expressed on Myeloid Cells 2 Mediates the Involvement of M2-Type Macrophages in Pulmonary Tuberculosis Infection. Journal of inflammation research. 2024;17:1919-1928. (Q2)
part of the research team - VEGA 1/0738/20 - Biomarkers of neuroinflammation in patients with Alzheimer's disease
responsible investigator of the grant - UK/245/2022 - Genetic polymorphisms in the promoter regions of MMP2 and the risk of developing Alzheimer's disease in the Slovak population
responsible investigator of the grant - UK/301/2023 - Genetic polymorphisms in the regulatory regions of the HLAG gene and the risk of developing Alzheimer's disease in the Slovak population